PRODUCT DESCRIPTION

O3: EVO Fusion by Panaxea Script operates through several mechanisms to protect the cardiovascular, endocrine, immune, and skeletal system in ageing women. It can be considered an essential co-prescription peri- and post-menopause but may be used in younger women when indicated. EVO Fusion has been subjected to extensive studies to arrive at the most efficacious standardisation of its ingredients.

Indications:

Primary

Oxidative stress
Osteoporosis prevention
Estrogen deficiency

Secondary

Women with a family history of cardiovascular disease post-menopause
Non ER+ breast cancer
Anaemia

Actions:

Increases production of oestrogen
Increases red blood cell production
Enhances myocardial mitochondria and red blood cell glutathione status
Stimulates blood circulation
Prevents platelet aggregation
Liver restorative
Enhances cardiovascular function
Helps prevent osteoporosis

RECOMMENDED USAGE

Take three capsules on empty stomach, for severe deficiency use six capsules daily

For relieve of peri-menopausal or menopausal symptoms add:
Fem+ (two to four capsules daily)
Change (five to six capsules daily)

COMPOSITION

Serving size: 1 capsule	Amount per serving
Extract dry conc. (10:1) equiv. to:
Astragalus membranaceus root Equiv: formononetin	4.17 g 59.2 mcg
Angelica polymorpha - root Equiv: ligustilide	833.30 mg 26.3 mcg

OTHER INGREDIENTS

Vegetable cellulose (hypromellose), vegetable stearic acid, microcrystalline cellulose and vegetable magnesium stearate

DOES NOT CONTAIN

Wheat, gluten, soy, milk, eggs, fish, crustacean shellfish, tree nuts and peanuts

STORAGE

Store in a cool dry place (<25°C), away from sunlight. Keep out of reach of children.

PRODUCT FORM

Capsule

WARNINGS/CONTRAINDICATIONS

If pregnant, nursing or taking medication, consult your healthcare practitioner before use.

Do not use this product if you have an allergy or sensitivity to any of the ingredients.

Please review package insert (if available) for further information.

Reset your password

Login